Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

Gene Weaver, a Cambridge Cluster biotech innovator, has received $515,214 from the Gates Foundation to support the ...

One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.

The UAE has long relied on rice imports to meet the demands of its diverse culinary culture. However, that dependency may ...

The Urgent Need for Sustainable Agriculture The United Nations designated the 15th November 2022 as the Day of Eight Billion. It marked the approximate date that the global population crossed the 8 ...

The University of Virginia Medical Center is not just one of Newsweek’s top 50 hospitals in the country (and No. 1 in the ...

Illumina Inc. today announced an expanded clinical oncology portfolio, unlocking the next new solutions to advance precision oncology and improve the standard of care. The company's broad range of ...

TransCode Therapeutics, Inc. , a clinical-stage oncology company developing RNA-targeted therapeutics for the treatment of cancer, today announced the appointment of Phillip D. Zamore, Ph.D., to its ...

Researchers have engineered a compact, high-specificity IscB variant, NovaIscB, for safe, persistent in vivo epigenome ...

How a Bold Russian Experiment Aims to Revive the Ice Age and Save the Planet. Discover the Science, Vision, and Controversy Behind This Ambitious Rewilding Project. The Vision: Reviving the Mammoth ...